Cerebrospinal fluid eosinophils in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease
- 9 March 2024
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 85, 105526
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaThe Lancet Neurology, 2023
- Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsJournal of Neuroinflammation, 2020
- Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patientsJournal of Neuroinflammation, 2020
- A case of myelin oligodendrocyte glycoprotein-antibody-associated disease presenting with tumefactive demyelinating lesionMultiple Sclerosis and Related Disorders, 2020
- Emerging therapeutic targets for neuromyelitis optica spectrum disorderExpert Opinion on Therapeutic Targets, 2020
- The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibodyActa Neuropathologica, 2020
- Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating SyndromesJAMA Neurology, 2020
- Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentationsMultiple Sclerosis and Related Disorders, 2019
- Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis opticaJournal of Clinical Investigation, 2013
- Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar puncturesJournal of the Neurological Sciences, 2011